| Share on Facebook Facebook | Share on StumbleUpon StumbleUpon |
| Share on LinkedIn LinkedIn | Submit to Reddit reddit |
| Tweet Twitter | Pin it Pinterest |
| Share on Google+ Google+ | Share on Digg Digg |
| Post to Tumblr Tumblr | Share on Delicious Delicious |
BBHVanEck Vectors Biotech ETF
Fund Description
VanEck Vectors® Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
-
Fund Ticker
BBH -
Exchange
NASDAQ -
Commencement
12/20/2011 -
ETF Structure
Physical -
Administrator
Van Eck Associates -
Custodian
Bank of New York Mellon -
Index Ticker
MVBBHTR -
Index Rebalancing
Quarterly
as of 09/17/19
-
30-Day SEC Yield1
0.43% -
Total Net Assets
$338.4M -
Number of Holdings
25 -
Options
Available -
Gross Expense Ratio2
0.40% -
Net Expense Ratio/TER2
0.35% -
Distribution Frequency
Annual -
Next Distribution Date
12/20/2019
Portfolio Composition (%)
as of 09/17/19
- % of Net Assets
-
Stocks
99.95 -
Bonds
0.00 -
Other
0.00 -
Cash
0.05
Daily Holdings (%) as of 09/17/19 Daily Holdings
Total Holdings: 25
Swipe
to view
full data
to view
full data
| Holding Name |
Ticker
|
Shares |
Market Value (US$) |
% of Net Assets |
|
|---|---|---|---|---|---|
| Amgen Inc |
AMGN US
|
183,199
|
36,038,907 | 10.65 | |
| Gilead Sciences Inc |
GILD US
|
403,138
|
26,675,641 | 7.88 | |
| Celgene Corp |
CELG US
|
250,077
|
24,657,592 | 7.29 | |
| Allergan Plc |
AGN US
|
136,155
|
22,615,346 | 6.68 | |
| Iqvia Holdings Inc |
IQV US
|
118,997
|
18,199,401 | 5.38 | |
| Biogen Inc |
BIIB US
|
72,246
|
17,245,120 | 5.10 | |
| Vertex Pharmaceuticals Inc |
VRTX US
|
97,566
|
17,171,616 | 5.07 | |
| Incyte Corp |
INCY US
|
197,663
|
15,635,143 | 4.62 | |
| Illumina Inc |
ILMN US
|
49,087
|
14,641,179 | 4.33 | |
| Exact Sciences Corp |
EXAS US
|
133,443
|
14,261,053 | 4.21 | |
| Beigene Ltd |
BGNE US
|
106,670
|
14,199,910 | 4.20 | |
| Regeneron Pharmaceuticals Inc |
REGN US
|
48,940
|
14,100,593 | 4.17 | |
| Alexion Pharmaceuticals Inc |
ALXN US
|
124,185
|
13,390,869 | 3.96 | |
| Biomarin Pharmaceutical Inc |
BMRN US
|
173,268
|
12,995,100 | 3.84 | |
| Qiagen Nv |
QGEN US
|
335,876
|
11,463,448 | 3.39 | |
| Neurocrine Biosciences Inc |
NBIX US
|
96,988
|
9,835,553 | 2.91 | |
| Charles River Laboratories Internationa |
CRL US
|
69,374
|
9,320,397 | 2.75 | |
| Alnylam Pharmaceuticals Inc |
ALNY US
|
99,042
|
8,697,868 | 2.57 | |
| Grifols Sa |
GRFS US
|
416,629
|
8,270,086 | 2.44 | |
| Sarepta Therapeutics Inc |
SRPT US
|
91,448
|
7,762,106 | 2.29 | |
| Ionis Pharmaceuticals Inc |
IONS US
|
98,504
|
6,381,089 | 1.89 | |
| Seattle Genetics Inc |
SGEN US
|
73,453
|
5,284,943 | 1.56 | |
| United Therapeutics Corp |
UTHR US
|
51,535
|
4,425,310 | 1.31 | |
| Nektar Therapeutics |
NKTR US
|
132,281
|
2,738,217 | 0.81 | |
| Bluebird Bio Inc |
BLUE US
|
20,917
|
2,232,262 | 0.66 | |
| Other/Cash |
--
|
--
|
177,065 | 0.05 |
These are not recommendations to buy or to sell any security. Securities and holdings may vary.